Podcast

In this episode, host Shikha Jain, MD, speaks with Stephen Beeson, MD, about the challenges physicians face when prioritizing work life balance, components for building skills to lead in health care and more.

In this edition, surgery confers higher 5-year survival rates than radiotherapy; first-line combination extends PFS in lung cancer subgroup; pembrolizumab improves outcomes in early-stage resectable lung cancer, and more.

Hosts Jim Mazzo and John A. Hovanesian, MD, FACS, chat with Stephen McLeod, MD, about his new position and the future of the American Academy of Ophthalmology.

In this edition, cross-border partnership takes on survival gap for children with leukemia; ‘paradigm shift’ in transfusion-dependent myelodysplastic syndrome; FDA approves Ayvakit for mastocytosis and more.

In this edition, FDA approves supplemental new drug application for Rexulti, early amyloid PET provides high diagnostic confidence, Leqembi reduced biomarkers of Alzheimer’s and more.

In this podcast episode, Douglas Rex, MD, discusses the importance of intent-to-treat for colorectal screenings, how screening technology has transformed gastroenterology practice and more.

In this episode, host Shikha Jain, MD, speaks with Ken Bloom, MD, FCAP, about developing technologies to assist cancer analysis and pathology, the spatial component of antibody conjugates and more.

In this edition, we bring you a deep dive on a collaboration that aims to accelerate better treatments for pediatric cancers.

In this edition, tumor mutational burden linked to immunotherapy response; toripalimab regimen extends EFS in stage III NSCLC; phase 3 study designed for increasing trial diversity, and more.

In this episode, host Shikha Jain, MD, speaks with Edward Kim, MD about what it means to be a disruptive innovator, how to lead efforts in health care system changes and more.